ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 280 out of 1499

$595K Total Retail Price of All Prescriptions

Rank: 239 out of 1499

371 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 371 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 371 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 7,770 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
AMLODIPINE BESYLATE 379 315 1 6
LEVOTHYROXINE SODIUM 363 315 2 2
SIMVASTATIN 342 288 3 3
FUROSEMIDE 342 257 3 7
HYDROCODONE-ACETAMINOPHEN 302 153 S3 5 4
LISINOPRIL 282 209 6 1
MIRTAZAPINE 260 224 7 50
GABAPENTIN 236 135 8 13
WARFARIN SODIUM 204 121 9 12
DONEPEZIL HCL 198 198 10 35
NAMENDA 188 188 11 47
METOPROLOL TARTRATE 169 131 12 10
CYMBALTA 153 96 13 40
POTASSIUM CHLORIDE 145 117 14 11
TRAZODONE HCL 130 92 15 32
CITALOPRAM HBR 125 94 16 14
FLUTICASONE PROPIONATE 122 82 17 31
COUMADIN 121 44 18 191
HYDROCHLOROTHIAZIDE 117 90 19 9
OXYCODONE HCL 110 0 S2 20 79
OMEPRAZOLE 109 72 21 5
CARBIDOPA-LEVODOPA 104 86 22 92
QUETIAPINE FUMARATE 104 77 22 72
ATENOLOL 102 74 24 21
ZOLPIDEM TARTRATE 98 77 25 23
GLIMEPIRIDE 96 78 26 38
SERTRALINE HCL 96 60 26 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 85 28 25
RISPERIDONE 90 65 29 74
ATORVASTATIN CALCIUM 89 62 30 17
CARVEDILOL 88 60 31 22
PANTOPRAZOLE SODIUM 88 79 31 48
OXYBUTYNIN CHLORIDE ER 83 32 33 141
TAMSULOSIN HCL 82 47 34 29
METFORMIN HCL 80 30 35 8
LANTUS 78 41 36 46
METOPROLOL SUCCINATE 78 55 36 20
NAPROXEN 77 57 38 63
NYSTOP 75 37 39 208
PRAVASTATIN SODIUM 75 75 39 18
LANTUS SOLOSTAR 69 53 41 89
KLOR-CON M20 68 40 42 97
BUPROPION HCL SR 65 29 43 151
CIPROFLOXACIN HCL 61 53 44 65
CRESTOR 60 48 45 34
DILTIAZEM 24HR CD 59 36 46 82
DIOVAN 58 25 47 58
COLESTIPOL HCL 58 50 47 293
BACLOFEN 58 15 47 119
CLONIDINE HCL 56 30 50 57
BUSPIRONE HCL 51 0 51 94
DIGOXIN 50 40 52 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.